3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Neoplasms
2
Brain Neoplasms
2
Sarcoma
1
Pituitary Neoplasms
1
Osteosarcoma
1
Oligodendroglioma
1
Neurotoxicity Syndromes
1
Neurofibromatosis 1
1
Multiple Myeloma
1
Meningioma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Hodgkin Disease
1
Glioma
1
Fatigue
1
Cytokine Release Syndrome
1
Astrocytoma
1
Interventions
tocilizumab
1
lopinavir-ritonavir drug combination
1
Piperacillin, Tazobactam Drug Combination
1
Oxygen Inhalation Therapy
1
Neuropsychological Tests
1
Methylprednisolone
1
Magnetic Resonance Spectroscopy
1
Lopinavir
1
Hydroxychloroquine
1
Heparin, Low-Molecular-Weight
1
Contrast Media
1
Azithromycin
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Cytokine Release Syndrome
×
Neuropsychological Tests
×
Clear all
NCT05510596
2024-08-09
MR-ICANS
University Hospital, Montpellier
Phase NA
Completed
25 enrolled